Literature DB >> 10738913

Metabolic myopathies: a clinical approach; part I.

B T Darras1, N R Friedman.   

Abstract

Children and adults with metabolic myopathies have underlying deficiencies of energy production, which may result in dysfunction of muscle or other energy-dependent tissues, or both. Patients with disorders of glycogen, lipid, or mitochondrial metabolism in muscle may present with dynamic findings (i.e., exercise intolerance, reversible weakness, and myoglobinuria) or progressive muscle weakness, or both. In this first part of the review, we present a brief description of energy metabolism in muscle, a simplified overview of the clinical and laboratory evaluation of the patient with suspected metabolic myopathy, and a diagnostic algorithm aimed at predicting the nature of the underlying biochemical abnormality. The goal is to simplify a complex field of neuromuscular disease and thus lead to early recognition and treatment of these disorders.

Entities:  

Mesh:

Year:  2000        PMID: 10738913     DOI: 10.1016/s0887-8994(99)00133-2

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  16 in total

Review 1.  A diagnostic algorithm for metabolic myopathies.

Authors:  Andres Berardo; Salvatore DiMauro; Michio Hirano
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

2.  Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome.

Authors:  Brian Bennett; Daniel Helbling; Hui Meng; Jason Jarzembowski; Aron M Geurts; Marisa W Friederich; Johan L K Van Hove; Michael W Lawlor; David P Dimmock
Journal:  Free Radic Biol Med       Date:  2016-01-08       Impact factor: 7.376

3.  Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.

Authors:  Barbara Gürtl; Dagmar Kratky; Christian Guelly; Lefeng Zhang; Gregor Gorkiewicz; Suman Kumar Das; Kuppusamy Palaniappan Tamilarasan; Gerald Hoefler
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  Exertional rhabdomyolysis, profound lactic acidosis, and acute kidney injury in a young boy: Answers.

Authors:  Min-Hua Tseng; Shao-Hsuan Hsia; Ching-Shiang Chi; Ju-Li Lin; Jainn-Jim Lin; Shih-Hua Lin
Journal:  Pediatr Nephrol       Date:  2015-07-09       Impact factor: 3.714

Review 5.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 6.  Respiratory involvement in inherited primary muscle conditions.

Authors:  N Shahrizaila; W J M Kinnear; A J Wills
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10       Impact factor: 10.154

7.  A novel MYH2 mutation in family members presenting with congenital myopathy, ophthalmoplegia and facial weakness.

Authors:  Tracey Willis; Carola Hedberg-Oldfors; Zoya Alhaswani; Richa Kulshrestha; Caroline Sewry; Anders Oldfors
Journal:  J Neurol       Date:  2016-05-13       Impact factor: 4.849

Review 8.  Pediatric Paroxysmal Exercise-Induced Neurological Symptoms: Clinical Spectrum and Diagnostic Algorithm.

Authors:  Federica Rachele Danti; Federica Invernizzi; Isabella Moroni; Barbara Garavaglia; Nardo Nardocci; Giovanna Zorzi
Journal:  Front Neurol       Date:  2021-06-01       Impact factor: 4.003

9.  Adriamycin inhibits glycolysis through downregulation of key enzymes in Saccharomyces cerevisiae.

Authors:  Uma Priya Mohan; Selvaraj Kunjiappan; P B Tirupathi Pichiah; Sankarganesh Arunachalam
Journal:  3 Biotech       Date:  2021-01-02       Impact factor: 2.406

10.  The "etiome": identification and clustering of human disease etiological factors.

Authors:  Yueyi I Liu; Paul H Wise; Atul J Butte
Journal:  BMC Bioinformatics       Date:  2009-02-05       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.